Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6303 of 6351
-
Maribavir drug study compares japanese and caucasian adults
Knowledge-focused CompletedThe purpose of this study is to compare the pharmacokinetics (PK), safety, and tolerability of maribavir administered as a single oral dose in healthy, adult participants of Japanese descent and matched, healthy, adult, non-Hispanic, Caucasian participants. In addition, this stud…
Phase 1 • Sponsor: Shire • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:07 UTC
-
Withdrawn study aimed to boost mental health in young south asian women
Knowledge-focused CancelledThe mental health sector is being called upon to develop and implement interventions for youth that attend to gender, age and cultural diversity (Mental Health Commission of Canada, 2016). The proposed project outlines the development and feasibility testing of a culturally drive…
Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Old tuberculosis vaccine put to test against COVID-19 – but trial never got off the ground
Prevention CancelledUntil the first half of April, Colombia has more than 2,800 infected cases and a hundred deaths as a result of COVID-19, with Antioquia being the third department with the highest number of cases. Official records indicate that, in Colombia, the first case was diagnosed on March …
Phase 3 • Sponsor: Universidad de Antioquia • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New study tracks pregnancy safety of rare disease drug
Knowledge-focused Recruiting nowThe purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 09, 2026 19:00 UTC
-
Healthy volunteers test new drug VNRX-5024 in early safety study
Knowledge-focused CompletedThis is a 2-part dose-ranging study to evaluate the safety and pharmacokinetics of escalating doses of VNRX-5024. Subjects will be enrolled in one of three dose cohorts. They will receive a single dose on Day 1 in Part 1 and will proceed into the multiple dose Part 2 of the study…
Phase 1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Experimental drug BI 1569912 tested in healthy men for safety
Knowledge-focused Stopped earlySRD-Part: To investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses (SRD) of BI 1569912 BA/FE-Part: To investigate (a) the relative bioavailability (BA) of BI 1569912 and (b) the influence of food (FE) on the relative bioavailability…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Depression dose study pulled before starting
Knowledge-focused CancelledThe aims of this study are to: 1. Determine the proportion of participants who are underdosed or overdosed under recommended dosing regimen of sertraline for the depression treatment (100 mg/day) 2. Determine and quantify clinical benefits of personalized sertraline dosing regim…
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Withdrawn study sought to identify which cancer patients could safely be treated at home for fever
Knowledge-focused CancelledThis study investigates the major complication rate in cancer patients potentially eligible for a hospital at home program for management of neutropenic fever. "Hospital at Home" is a home care program that provides acute, inpatient care in a patient's home in place of a traditio…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:35 UTC
-
Tiny blood cell powerhouses under the microscope: no cure, just better science
Knowledge-focused CompletedThe research study is about blood cells (platelets) and their power houses (mitochondria). The investigators want to learn about their behavior in order to ensure that our laboratory procedures are generating optimal results.
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
COVID steroid trial pulled before it even started
Disease control CancelledTo date, there is no efficient therapeutics to prevent or treat COVID-19 related pulmonary failure. Corticosteroids (CS) could be a helpful therapeutic. Retrospective reports suggested survival improvement in patients with acute respiratory distress syndrome (ARDS). CT scan for C…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Fat grafts aim to soothe painful fingertip amputations
Symptom relief CancelledThe purpose of this study is to evaluate the contribution of autologous graft reinjection (lipofilling) in the treatment of dysaesthesic pulp.
Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Alcohol and cirrhosis: can a quick test spot brain problems?
Knowledge-focused Stopped early80% of patients with alcohol use disorders (AUD) present cognitive impairments, such as memory and executive functions. These disorders may have repercussions in addiction treatment by altering the patient's adherence to care. The level of impairment is dependent on the onset of …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Hormones and the spine: scientists probe Estrogen's role in nerve flexibility
Knowledge-focused Recruiting nowThe goal of this project is to test our central hypothesis that the spinal cord neuroplasticity in females will be modulated by the level of estradiol concentration. under aim 1 we will determine the influence of estradiol fluctuations on spinal circuit excitability post afferent…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Sticker shock: simple reminder may cut unnecessary IV antibiotic use
Knowledge-focused Stopped earlyA single-center, cluster-randomized controlled trial was conducted to determine the effect of Sticker reminder intervention on IV-to-PO switching of fluoquinolone.
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New eye scanner put to the test in small study
Knowledge-focused CompletedThe EYESTAR 900 with software version i9.5.1.0 includes new analysis functionality. Since its clinical performance cannot be assessed based solely on clinical literature as found in the Clinical Evaluation Report, further data from a clinical trial is required. The objective of t…
Sponsor: Haag-Streit AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Virtual reality vs. slideshow: which teaches nursing students more about MS?
Knowledge-focused OngoingThis study compared two educational methods. Participants were assigned to participate in a 360-degree experience or a slideshow presentation. The 360-degree video group included a brain and MS program. The comparison group was given a slideshow presentation with the same informa…
Sponsor: Hunter College of City University of New York • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Laser study on burn scar pain and itch withdrawn before start
Knowledge-focused CancelledHypertrophic Burn Scars (HTBS) are often treated with Fractional CO2 laser therapy to improve cosmetic appearance. It has been noted that this leads to a reduction in the pain and itch associated with this type of scars. While this phenomenon is commonly described in the literatu…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Study on GLP-1 for type 1 diabetes withdrawn before it began
Knowledge-focused CancelledThe hypotheses to be tested in this application is: GLP-1 will acutely protect arterial endothelial function and reduce pro-atherothrombotic and pro-coagulant effects of repeated hypoglycemia in T1DM.
Early phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Cancer drug trial pulled before it even started
Disease control CancelledThis phase I trial studies the side effects and best dose of CB-5339 in treating patients with solid tumors that has spread to other places in the body (advanced) or lymphomas. CB-5339 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 26, 2026 18:21 UTC
-
Pain relief study pulled before it began
Knowledge-focused CancelledThis study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC